期刊论文详细信息
LIFE SCIENCES 卷:257
Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation
Review
Paniri, Alireza1,2  Akhavan-Niaki, Haleh2,3 
[1] Babol Univ Med Sci, Student Res Comm, Babol, Iran
[2] Babol Univ Med Sci, Fac Med, Genet Dept, Babol, Iran
[3] Pasteur Inst Iran, Zoonoses Res Ctr, Amol, Iran
关键词: SARS-CoV-2;    COVID-19;    Inflammation;    Cytokine release syndrome;    Inflammasome;    Drug;   
DOI  :  10.1016/j.lfs.2020.118114
来源: Elsevier
PDF
【 摘 要 】

The world has witnessed a high morbidity and mortality caused by SARS-CoV-2, and global death toll is still rising. Exaggerated inflammatory responses are thought to be more responsible for infiltrated immune cells accumulation, organ damage especially lung, dyspnea, and respiratory failure rather than direct effect of viral replication. IL-6 and NLRP3 inflammasome are the major immune components in immune responses stimulation upon pathogen infection. It's noteworthy that the function and expression of these components are remarkably influenced by non-coding RNAs including long non-coding RNAs. Given the potential role of these components in organ damage and pathological manifestations of patients infected with COVID-19, their blockage might be a hopeful and promising treatment strategy. Notably, more study on long non-coding RNAs involved in inflammatory responses could elevate the efficacy of anti-inflammatory therapy. In this review we discuss the potential impact of IL-6 and NLRP3 inflammasome blocker drugs on inflammatory responses, viral clearance, and pathological and clinical manifestations. Collectively, anti-inflammatory strategy might pave the way to diminish clinical and pathological manifestations and thereby discharging patients infected with COVID-19 from hospital.

【 授权许可】

Free   

【 预 览 】
附件列表
Files Size Format View
10_1016_j_lfs_2020_118114.pdf 2634KB PDF download
  文献评价指标  
  下载次数:0次 浏览次数:0次